Powered exoskeletons are no longer science fiction. FDA-cleared rehabilitation devices are restoring mobility to SCI patients. Industrial exos are reducing worker injuries at Ford and Boeing. And consumer exos just broke the $1,200 price point. Here's the complete 2026 guide.
FDA-cleared devices for SCI (spinal cord injury), stroke, and neurological rehabilitation. Require physician prescription and trained therapist. Insurance coverage varies by state.
Reduces fatigue and injury risk for workers doing heavy lifting, overhead work, or repetitive tasks. No FDA required. ROI measured in workers' comp claims and productivity.
Force augmentation for soldiers carrying heavy loads or operating in hazardous environments. Procurement through defense contracting, not commercial channels.
Accessible devices for everyday people — hikers, aging adults, commuters. Not FDA-cleared for medical claims. Focus on comfort and lifestyle enhancement.
The clinical gold standard for lower-body rehabilitation. If you're setting up a rehab clinic or comparing exos for SCI recovery, Ekso GT has the most evidence. Expensive but validated.
The only lower-body exo FDA-approved for independent personal use. If independence outside a clinic is the goal, ReWalk 6.0 is the answer. Training required but users can eventually operate solo.
The power suit for industrial workers. 200 lb lift assist and an all-day battery make this the most capable exo for manufacturing. The subscription pricing democratizes access.
Best modular approach: buy just a back assist for $15K, add shoulder for overhead work, add leg for squatting tasks. Ottobock's backing means long-term support is reliable.
The breakthrough consumer exo. Not medical-grade, but at $1,200 it brings wearable power assist to hikers, aging adults, and workers who can't justify $40K+ clinical solutions.
The most widely deployed industrial exo. Ford, Boeing, and GM use this on assembly lines. If your workers do overhead arm work for hours, EksoVest pays for itself in reduced workers' comp claims.
Less wearable exo, more powered robot suit. The Guardian XT sits at the intersection of exoskeleton and industrial robot. Excellent for hazardous tasks where force amplification matters more than mobility.
A strong alternative to Ekso GT and ReWalk at a similar price point. The lighter weight and adaptive gait algorithm are genuine advantages. Worth evaluating alongside the market leaders.
The exoskeleton market in 2026 has bifurcated sharply: premium medical and military devices (Ekso, Sarcos, ReWalk) remain expensive at $60-200K, while the consumer segment has exploded with Hypershell X and similar companies bringing hip assist to hikers and commuters for under $2K. Insurance reimbursement for medical exos remains the key adoption bottleneck in the US.